Byrne Asset Management LLC Arcturus Therapeutics Holdings Inc. Transaction History
Byrne Asset Management LLC
- $115 Million
- Q4 2024
A detailed history of Byrne Asset Management LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Byrne Asset Management LLC holds 1,520 shares of ARCT stock, worth $25,596. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,520
Previous 1,840
17.39%
Holding current value
$25,596
Previous $44,000
43.18%
% of portfolio
0.02%
Previous 0.04%
Shares
14 transactions
Others Institutions Holding ARCT
# of Institutions
177Shares Held
25.4MCall Options Held
195KPut Options Held
133K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$79 Million0.25% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$44.6 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.32MShares$39 Million0.62% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$35.4 Million0.46% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$34.8 Million0.02% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $448M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...